Medtronic Plc Stock Today
| MDT Stock | USD 84.74 0.63 0.75% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Medtronic PLC is selling for under 84.74 as of the 21st of November 2024; that is 0.75 percent increase since the beginning of the trading day. The stock's last reported lowest price was 83.92. Medtronic PLC has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Note, on September 12, 2024, Senator Tommy Tuberville of US Senate acquired $15k to $50k worth of Medtronic PLC's common stock.
Business Domain Health Care Equipment & Services | IPO Date 13th of January 1978 | Category Healthcare | Classification Health Care |
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The company was founded in 1949 and is headquartered in Dublin, Ireland. Medtronic operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. The company has 1.28 B outstanding shares of which 10.18 M shares are now shorted by investors with about 2.19 days to cover. More on Medtronic PLC
Moving against Medtronic Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Medtronic Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Chairman | Omar Ishrak | ||||
| Thematic Ideas | Showing 3 out of 4 themes | ||||
| Old Names | [MEDTRONIC, MEDTRONIC] | ||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, SP 500 Index, Nasdaq CTA Artificial, SP 100 Index, SP 100, ARCA Institutional, Dividend Beast, Obamacare Repeal, Macroaxis Picks, Giant Impact, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | ||||
| Excise Tax Activities | Animal Testing | ||||
| Average Analyst Recommendation | |||||
Debt LevelsMedtronic PLC can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Medtronic PLC's financial leverage. It provides some insight into what part of Medtronic PLC's total assets is financed by creditors.
| |||||
Medtronic PLC (MDT) is traded on New York Stock Exchange in USA. It is located in Building Two, Galway, Ireland and employs 95,000 people. Medtronic PLC is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a total capitalization of 107.88 B. Medtronic PLC runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 1.28 B outstanding shares of which 10.18 M shares are now shorted by investors with about 2.19 days to cover.
Medtronic PLC has about 1.54 B in cash with 6.79 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.59.
Check Medtronic PLC Probability Of Bankruptcy
Ownership AllocationMedtronic PLC maintains a total of 1.28 Billion outstanding shares. The majority of Medtronic PLC outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Medtronic PLC to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Medtronic PLC. Please pay attention to any change in the institutional holdings of Medtronic PLC as this could imply that something significant has changed or is about to change at the company. Please note that on September 12, 2024, Senator Tommy Tuberville of US Senate acquired $15k to $50k worth of Medtronic PLC's common stock.
Check Medtronic Ownership Details
Medtronic Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Franklin Resources Inc | 2024-06-30 | 19.7 M | |
| Deutsche Bank Ag | 2024-06-30 | 16.7 M | |
| Norges Bank | 2024-06-30 | 15.6 M | |
| Legal & General Group Plc | 2024-06-30 | 11.6 M | |
| Royal Bank Of Canada | 2024-06-30 | 11.4 M | |
| Northern Trust Corp | 2024-09-30 | 11.4 M | |
| Ameriprise Financial Inc | 2024-06-30 | 10.9 M | |
| Amvescap Plc. | 2024-06-30 | 10.8 M | |
| Alliancebernstein L.p. | 2024-06-30 | 10.7 M | |
| Vanguard Group Inc | 2024-09-30 | 123.4 M | |
| Blackrock Inc | 2024-06-30 | 111.9 M |
Medtronic PLC Historical Income Statement
Medtronic Stock Against Markets
Medtronic PLC Corporate Directors
| Scott Donnelly | Lead Independent Director | Profile | |
| Richard Anderson | Lead Independent Director | Profile | |
| Elizabeth Nabel | Independent Director | Profile | |
| James Lenehan | Independent Director | Profile |
Additional Tools for Medtronic Stock Analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.